|
Report Date : |
26.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
REMEDY PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
23 K.M., |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
2009 |
|
|
|
|
Com. Reg. No.: |
0068745 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of
Pharmaceutical Products |
|
|
|
|
No. of Employees : |
44 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
REMEDY
PHARMACEUTICALS (PVT) LIMITED
|
Registered
Address & Factory |
|
23 K.M., Thokar Raiwind Road Behind Alamgeer Granite, Lahore, Pakistan |
|
Tel # |
92 (42) 35321177 |
|
Fax # |
92 (42) 35321177 |
|
a. |
Nature of Business |
Manufacture
& Marketing of Pharmaceutical Products |
|
b. |
Year Established |
2009 |
|
c. |
Registration # |
0068745 |
None
|
Muhammad Tahir
Warraich (Chartered Accountants) 139-N, Marghzar
Officer Colony, Multan Road, Lahore, Pakistan |
|
Subject Company was established as a Private Limited Company in 2009 |
|
|
Authorized Capital |
Rs. 3,300,000/-
divided into 33,000 shares of Rs. 100/- each |
|
|
Issued & Paid up Capital |
Rs. 3,000,000/-
divided into 30,000 shares of Rs. 100/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Shahid Munir Mr. Muhammad Asif Mr. Muhammad Tahir Khan |
Pakistani Pakistani Pakistani |
58-E, Staff Colony, New Campus, Lahore 55 - Karim Block, Allama Iqbal Town, Lahore 22-A, Karim Block, Allama Iqbal Town, Lahore |
Business Business Business |
Chief Executive Director Director |
|
Names |
No. of
Shares |
|
Mr. Shahid Munir Mr. Muhammad Asif Mr. Muhammad Tahir Khan |
10,000 10,000 10,000 |
A. Subsidiary
None
B. Associated Companies
(1) Trigon Pharmaceuticals (Pvt) Ltd, Pakistan.
(2) Excel Pharmaceutical Industries, Pakistan.
Manufacture & marketing of different pharmaceutical class like Anti
Biotic, Anti Malarials, Anti-Rheumatic, Antihistamine, Narcotic Analgesic, Non
Steroidal Respiratory Anti Inflamatory, Quinolones, Vitamins, Phenothiazine,
Hypolipidaemics, Muscle Relaxant etc
44
The capacity and production of the company’s
plant is indeterminable as it is multi-product and involves varying processes
of manufacturing.
|
Year |
In Pak Rupees |
|
2011 |
Not ascertained as the subject is a new Company |
Subject mainly import from Companies belongs to China & India
|
Mainly exist at major cities of Punjab
Province |
(1)
Habib Bank Limited,
Pakistan.
(2)
Bank Alfalah Limited,
Pakistan.
(3)
Faysal Bank Limited,
Pakistan.
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 91.00 |
|
UK Pound |
1 |
Rs. 141.80 |
|
Euro |
1 |
Rs. 118.10 |
Subject Company
was established in 2009 and is engaged in manufacture & marketing of
Pharmaceutical Products. Trade relations are not known. Such as conducting
business activity with the subject is considered to be a trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.90 |
|
|
1 |
Rs.80.77 |
|
Euro |
1 |
Rs.67.40 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.